Morning-after pill denial faces challenge from dormant lawsuit
Summary of story from Reuters, December 19, 2011
A dormant, six-year old lawsuit may offer reproductive rights advocates their best chance at challenging a US directive which denies girls under 17 over-the-counter access to the morning-after pill.
The lawsuit, filed in 2005, charged that the US Food and Drug Administration’s (FDA) refusal at the time to make the Teva Pharmaceutical Industries drug, known as Plan B, available over the counter to girls and women of all ages was “not supported by medical or scientific evidence.”
Since then, the FDA has allowed sales of the drug without a prescription for women aged 17 and older.
Despite this, Health and Human Services Secretary Kathleen Sebelius on December 7 overruled an FDA recommendation and refused to lift a requirement that girls under 17 get a prescription for Plan B (see WVoN story).
Women’s health advocates said the ruling went against President Barack Obama’s pledge to reassert the power of science in his administration’s decisions.
If the lawsuit is revived, it could be a good vehicle with which to challenge Sebelius’s decision, according to legal experts and advocates for women’s reproductive rights.
If the court were to find that the government relied improperly on politics instead of science, it could order that Plan B be made available immediately over the counter to girls under 17.











